Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Free Report) saw a significant drop in short interest in June. As of June 15th, there was short interest totalling 39,000 shares, a drop of 42.8% from the May 31st total of 68,200 shares. Based on an average trading volume of 483,000 shares, the short-interest ratio is currently 0.1 days. […]
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Free Report) was the target of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 39,000 shares, a decline of 42.8% from the May 31st total of 68,200 shares. Based on an average daily trading volume, of 483,000 shares, […]
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Get Rating) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 206,200 shares, a growth of 320.8% from the March 31st total of 49,000 shares. Currently, 14.1% of the company’s shares are short sold. Based on an average […]
Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Rating) is scheduled to be issuing its quarterly earnings data on Friday, March 31st. Eloxx Pharmaceuticals Price Performance Shares of Eloxx Pharmaceuticals stock traded down $0.12 during trading hours on Thursday, reaching $2.35. The company’s stock had a trading volume of 673 shares, compared to its average volume of 128,304. […]